| abstract |
The invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been indicated. Given that certain members of said family are novel compounds which have never been described, the invention relates to said novel products, the synthesis methods thereof, and certain novel intermediate synthesis products. The invention further relates to compositions comprising the compounds of said family, and the use of said compounds as medicaments, especially for the preparation of a medicament for the treatment of neurodegenerative diseases. |